Cargando…
Robenacoxib shows efficacy for the treatment of chronic degenerative joint disease-associated pain in cats: a randomized and blinded pilot clinical trial
The main objective of this pilot clinical trial was to evaluate outcome measures for the assessment of the nonsteroidal anti-inflammatory drug (NSAID) robenacoxib in cats with degenerative joint disease-associated pain (DJD-pain). Otherwise healthy cats (n = 109) with DJD-pain entered a parallel gro...
Autores principales: | Adrian, Derek, King, Jonathan N., Parrish, Rudolph S., King, Stephen B., C. Budsberg, Steven, Gruen, Margaret E., Lascelles, B. Duncan X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032665/ https://www.ncbi.nlm.nih.gov/pubmed/33833276 http://dx.doi.org/10.1038/s41598-021-87023-2 |
Ejemplares similares
-
Clinical safety of robenacoxib in cats with chronic musculoskeletal disease
por: King, Jonathan N., et al.
Publicado: (2021) -
Development of a checklist for the detection of degenerative joint
disease-associated pain in cats
por: Enomoto, Masataka, et al.
Publicado: (2020) -
Efficacy and Safety of an Anti-nerve Growth Factor Antibody (Frunevetmab) for the Treatment of Degenerative Joint Disease-Associated Chronic Pain in Cats: A Multisite Pilot Field Study
por: Gruen, Margaret E., et al.
Publicado: (2021) -
Criterion Validation Testing of Clinical Metrology Instruments for Measuring Degenerative Joint Disease Associated Mobility Impairment in Cats
por: Gruen, Margaret E., et al.
Publicado: (2015) -
Detection of Clinically Relevant Pain Relief in Cats with Degenerative Joint Disease Associated Pain
por: Gruen, M.E., et al.
Publicado: (2014)